Published in J Physiol on September 01, 1998
Neuromuscular effects of candoxin, a novel toxin from the venom of the Malayan krait (Bungarus candidus). Br J Pharmacol (2003) 0.88
Factors influencing the low-frequency associated nicotinic ACh autoreceptor-mediated depression of ACh release from rat motor nerve terminals. Br J Pharmacol (2000) 0.81
Calmodulin increases transmitter release by mobilizing quanta at the frog motor nerve terminal. Br J Pharmacol (2002) 0.75
Quantal components of the end-plate potential. J Physiol (1954) 37.52
A further study of the statistical composition on the end-plate potential. J Physiol (1955) 19.64
The effect of magnesium on the activity of motor nerve endings. J Physiol (1954) 17.71
Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox. J Physiol (1975) 5.09
Drug blockade of open end-plate channels. J Physiol (1976) 4.60
Intraterminal injection of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse. Proc Natl Acad Sci U S A (1985) 3.23
A quantitative analysis of local anaesthetic alteration of miniature end-plate currents and end-plate current fluctuations. J Physiol (1977) 3.05
Synapsin I bundles F-actin in a phosphorylation-dependent manner. Nature (1987) 2.59
Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions. J Physiol (1975) 1.88
A voltage-clamp study of the effect of two lidocaine derivatives on the time course of end-plate currents. J Physiol (1976) 1.83
Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature (1992) 1.67
Actions of dimethylphenylpiperazinium. Br J Pharmacol Chemother (1959) 1.56
Transversaly cut diaphragm preparation from rat. An adjuvant tool in the study of the physiology and pbarmacology of the myoneural junction. Arch Int Pharmacodyn Ther (1968) 1.42
Pharmacology and toxicology of the monovalent carboxylic ionophores. Annu Rev Pharmacol Toxicol (1982) 1.36
The statistics of transmitter release at chemical synapses. Int Rev Physiol (1978) 1.34
Prolonged exposure to acetylcholine: noise analysis and channel inactivation in cat tenuissimus muscle. J Physiol (1981) 1.33
Effects of synapsin I and calcium/calmodulin-dependent protein kinase II on spontaneous neurotransmitter release in the squid giant synapse. Proc Natl Acad Sci U S A (1990) 1.27
Presynaptic action of curare. J Physiol (1979) 1.19
Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.14
The molecular biology of neuronal nicotinic acetylcholine receptors. Crit Rev Toxicol (1997) 0.94
Fast desensitization of the nicotinic receptor at the mouse neuromuscular junction. Br J Pharmacol (1982) 0.92
Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J Physiol (1994) 0.92
Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals. Br J Pharmacol (1997) 0.89
Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors. Cell Mol Neurobiol (1997) 0.88
End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs. J Pharmacol Exp Ther (1990) 0.86
Electrophysiological analysis of transmission at the skeletal neuromuscular junction. J Pharmacol Toxicol Methods (1993) 0.86
Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction. J Physiol (1993) 0.85
Pharmacology of the nicotinic acetylcholine receptor from fetal rat muscle expressed in Xenopus oocytes. Eur J Pharmacol (1996) 0.84
[3H]acetylcholine release from the phrenic nerve is increased or decreased by activation or desensitization of nicotine receptors. Eur J Pharmacol (1987) 0.84
Relative pre- and postjunctional effects of a new vecuronium analogue, Org 9426, at the rat neuromuscular junction. Br J Anaesth (1992) 0.83
Effects of hexamethonium on transmitter release from the rat phrenic nerve. Neurosci Lett (1992) 0.83
Cholinergic agonists decrease quantal output at the frog neuromuscular junction by targeting a calcium channel blocked by omega-conotoxin. Pflugers Arch (1997) 0.79
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol (1983) 1.33
The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J Physiol (1987) 1.14
Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology (1994) 1.13
Acetylcholine transport, storage, and release. Int Rev Neurobiol (1993) 1.06
Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals. J Neurophysiol (1999) 1.06
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Br J Cancer (2009) 1.04
Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann Neurol (1987) 1.02
Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor. Muscle Nerve (1982) 0.98
Presynaptic receptors in the neuromuscular junction. Ann N Y Acad Sci (1990) 0.98
Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Ann Neurol (1985) 0.96
Collaborative study for establishment of the European Pharmacopoeia BRP batch 1 for diphtheria toxin. Pharmeuropa Bio (2003) 0.94
Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J Physiol (1994) 0.92
Systemic sarcoidosis and cutaneous lymphoma: is the association fortuitous? Br J Dermatol (1999) 0.92
Synthesis and neuromuscular blocking activity of 16beta-piperidinosteroidal derivatives. Eur J Med Chem (2001) 0.91
The effects of L-vesamicol, an inhibitor of vesicular acetylcholine uptake, on two populations of miniature endplate currents at the snake neuromuscular junction. Neuroscience (1990) 0.90
Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium. J Physiol (1991) 0.89
Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals. Br J Pharmacol (1997) 0.89
Urinary neopterin levels in acute viral hepatitis. Hepatology (1988) 0.86
Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment. Brain Dev (2008) 0.86
Acute pulmonary edema, capillaritis and alveolar hemorrhage: pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus? Lupus (2005) 0.85
Presynaptic function is altered in snake K+-depolarized motor nerve terminals containing compromised mitochondria. J Physiol (2001) 0.85
[Calcofluor-white staining in the identification of Pneumocystis carinii]. Pneumologie (1992) 0.85
The long-term results of surgical correction of childhood esotropia. Aust N Z J Ophthalmol (1993) 0.84
Relative pre- and postjunctional effects of a new vecuronium analogue, Org 9426, at the rat neuromuscular junction. Br J Anaesth (1992) 0.83
Interferon in lungs. Lancet (1989) 0.83
The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity. Curr Med Chem (2012) 0.83
alpha-Conotoxin GI produces tetanic fade at the rat neuromuscular junction. Toxicon (1992) 0.82
A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity. Br J Pharmacol (1988) 0.82
The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex. Mol Pharmacol (1986) 0.81
Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients. Nucleosides Nucleotides Nucleic Acids (2006) 0.81
Urinary neopterin, a marker of clinical activity in patients with Crohn's disease. Clin Chim Acta (1986) 0.80
Serum levels of interleukin 6, interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation. Transplantation (1994) 0.80
Cloning and sequence of the LYS2 homologue gene from the osmotolerant yeast Pichia sorbitophila. Yeast (2001) 0.80
Cytomegalovirus pneumonitis in heart-lung transplant recipients: histopathology and clinicopathologic considerations. Hum Pathol (1990) 0.79
Alpha-adrenoceptor blocking properties of vesamicol. Eur J Pharmacol (1991) 0.79
Multimodal therapy of small cell lung cancer in TNM stages I through IIIa. Ann Thorac Surg (1992) 0.78
Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med (2001) 0.78
Familial nephropathy associated with hyperuricemia in Spain: our experience with 3 families harbouring a UMOD mutation. Nucleosides Nucleotides Nucleic Acids (2006) 0.78
The effects of a 16-N-homopiperidino analogue of vecuronium on neuromuscular transmission in anaesthetized cats, pigs, dogs and monkeys, and in isolated preparations. Acta Anaesthesiol Scand (1991) 0.78
Automated cell differentiation of bronchoalveolar lavage samples with two-step image analysis. Anal Quant Cytol Histol (1996) 0.78
Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis carinii infection in a liver transplant patient receiving tacrolimus. Clin Transplant (1999) 0.77
[Is percutaneous liver biopsy using the Trucut (Travenol) needle superior to Menghini puncture?]. Z Gastroenterol (1989) 0.77
The effects of vesamicol on trains of endplate currents and on focally recorded nerve terminal currents at mammalian neuromuscular junctions. Br J Pharmacol (1992) 0.77
Hypoxanthine effects on cyclic AMP levels in human lymphocytes. Nucleosides Nucleotides Nucleic Acids (2004) 0.77
Non-Hodgkin's lymphoma of the lung diagnosed by gene rearrangement from bronchoalveolar lavage fluid: a fast and noninvasive method. Blood (1991) 0.77
Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants. Immunology (1986) 0.76
[The relation between the recurrent nerve and the inferior thyroid artery]. Arch Maragliano Patol Clin (1977) 0.76
A simple index relating clinical activity in Crohn's disease with T cell activation: hematocrit, frequency of liquid stools and urinary neopterin as parameters. Immunobiology (1986) 0.75
Atypical antipsychotics in the treatment of schizophrenia. Users' experiences of treatments must be considered. BMJ (2001) 0.75
Effect of veratridine on miniature endplate current amplitudes at the rat neuromuscular junction and acetylcholine uptake by Torpedo synaptic vesicles. Brain Res (1995) 0.75
[Infiltration of the splanchnic nerves in the treatment of acute pancreatitis]. Minerva Chir (1967) 0.75
Effects of hypoxanthine on adenosine transport in human lymphocytes. Implications in the pathogenesis of Lesch-Nyhan syndrome. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
[Sphincterotomy and choledochoduodenostomy in the treatment of biliary calculosis and non-neoplastic stenosis of the papilla considerations based on 25 years experience at the Prof. E. Tosatti School]. Arch Maragliano Patol Clin (1977) 0.75
[Selective arteriography in the study of chronic pancreatitis]. Atti Accad Fisiocrit Siena Med Fis (1968) 0.75
[Gastroesophageal reflux and cancer of the gastric stump]. Minerva Chir (1985) 0.75
[Further observations on potentiated cholangiography]. Minerva Chir (1969) 0.75
[Extensive surgery for cancer of the colorectum]. Minerva Chir (1986) 0.75
Extension of lymph node dissection and survival in primary gastric cancer. Int Surg (1993) 0.75
[Preliminary observations on cholangiography potentiated by intravenous infusion]. Ann Radiol Diagn (Bologna) (1968) 0.75
Synthesis and neuromuscular blocking activity of 16beta-N-methylpiperazino steroidal derivatives. Eur J Med Chem (2002) 0.75
Early visual recovery after excimer laser surgery for myopia: the Melbourne OmniMed results. Ophthalmic Surg Lasers (1996) 0.75
Waldenstrom macroglobulinaemia treated with sequential hemibody irradiation. J Clin Apher (1987) 0.75
[Dyspepsia in general practice consultation]. Acta Med Port (2001) 0.75
In-vitro smooth muscle relaxant activity of a series of vecuronium analogues in the rat aorta. J Pharm Pharmacol (1994) 0.75
[Possibilities and limitations of lymphography in the diagnosis of chronic pancreatitis]. Mem Acad Chir (Paris) (1968) 0.75
Heterotopic heart transplantation. Transplant Proc (1987) 0.75
[Variability of the relation between the terminal portion of the laryngeal nerve and the superior thyroid artery]. Arch Maragliano Patol Clin (1977) 0.75
[Considerations on phylloid tumors of the breast]. Atti Accad Fisiocrit Siena Med Fis (1964) 0.75
[Pneumococcal preventive vaccination. Consensus report, 3]. Wien Med Wochenschr (1998) 0.75
[Spectroscopic analysis of biliary calculi: correlations of the type of calculi and clinical data of 25 consecutive surgical patients]. G Chir (1994) 0.75
Characteristics of early onset esotropia. Aust N Z J Ophthalmol (1993) 0.75
[The deep lymphatics of the lower limb demonstrated by "retrograde lymphography"]. Arch Maragliano Patol Clin (1975) 0.75
[Pancreatic scintigraphy with electronic abstraction of hepatic image]. Lyon Chir (1970) 0.75
[Preliminary observations on changes in pancreatic blood flow studied with the use of rubidium (Rb86) in acute experimental pancreatitis]. Minerva Chir (1976) 0.75
[The prognostic value of Jass' histopathological classification of cancer of the left colon and rectum]. Minerva Chir (1990) 0.75
2 Characteristics of early onset esotropia. Strabismus (1994) 0.75
[Pancreatic calcifications]. Atti Accad Fisiocrit Siena Med Fis (1968) 0.75
Adenosine transport in HPRT deficient lymphocytes from Lesch-Nyhan disease patients. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
[Pancreatic scintigraphy with electronic subtraction of the hepatic image]. Acta Chir Belg (1969) 0.75
[Seroprevalence of parvovirus B19 in our area and its distribution by ages and sexes]. Enferm Infecc Microbiol Clin (2000) 0.75
Early recurrence of Wegener's granulomatosis in a kidney allograft under cyclosporine treatment. Transpl Int (1988) 0.75
[Malacoplakia of the urinary tract]. Urologe A (1988) 0.75
Cytomegalovirus pneumonitis. Lancet (1988) 0.75
Successful treatment of spinal sarcoidosis by high-dose intravenous methylprednisolone. Clin Neuropharmacol (1993) 0.75
Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus. Br J Dermatol (2000) 0.75
HPRT deficiency in Spain: what have we learned in the past 30 years (1984-2013)? Nucleosides Nucleotides Nucleic Acids (2014) 0.75
[Hypotonic duodenography obtained by pharmacologic test with morphine in the study of chronic pancreatitis]. Quad Radiol (1969) 0.75
[Recent acquisitions in surgery of the extrahepatic biliary passages]. Minerva Chir (1979) 0.75
Congenital myasthenia: further evidence of disease heterogeneity. Muscle Nerve (1986) 0.75
[Suture in a single layer after resection of the large intestine]. Minerva Chir (1970) 0.75
A new surgical treatment for lymphatic and venous edema. J Cardiovasc Surg (Torino) (1969) 0.75
[Surgery of Oddi's sphincter: papillo-infundibular divulsion]. Minerva Chir (1982) 0.75
[Current trends on pancreas transplantation]. Minerva Chir (1968) 0.75
[Acute interstitial nephritis and kidney failure requiring dialysis after sulfinpyrazone therapy]. Acta Med Austriaca (1984) 0.75
[Current acquisitions on the treatment of pseudocysts of the pancreas]. Minerva Chir (1977) 0.75
1 the long-term results of surgical correction of childhood esotropia. Strabismus (1994) 0.75
[Pancreatic scintiscanning with subtraction of the hepatic image]. Minerva Chir (1971) 0.75
Bronchiolitis obliterans with organizing pneumonia: atypical appearance on radiographs. AJR Am J Roentgenol (1992) 0.75